1. Home
  2. ETS vs BRTX Comparison

ETS vs BRTX Comparison

Compare ETS & BRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ETS

Elite Express Holding Inc.

N/A

Current Price

$0.53

Market Cap

9.0M

Sector

Industrials

ML Signal

N/A

Logo BioRestorative Therapies Inc. (NV)

BRTX

BioRestorative Therapies Inc. (NV)

HOLD

Current Price

$1.09

Market Cap

10.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ETS
BRTX
Founded
2020
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Trucking Freight/Courier Services
Managed Health Care
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.0M
10.1M
IPO Year
2025
N/A

Fundamental Metrics

Financial Performance
Metric
ETS
BRTX
Price
$0.53
$1.09
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
83.3K
27.2K
Earning Date
04-14-2026
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,585,885.00
$383,400.00
Revenue This Year
N/A
$112.14
Revenue Next Year
N/A
$139.81
P/E Ratio
N/A
N/A
Revenue Growth
6.59
1.70
52 Week Low
$0.49
$0.98
52 Week High
$4.23
$2.55

Technical Indicators

Market Signals
Indicator
ETS
BRTX
Relative Strength Index (RSI) 49.09 40.71
Support Level $0.52 $1.10
Resistance Level $0.58 $1.19
Average True Range (ATR) 0.03 0.06
MACD 0.00 -0.00
Stochastic Oscillator 38.07 20.36

Price Performance

Historical Comparison
ETS
BRTX

About ETS Elite Express Holding Inc.

Elite Express Holding Inc is a holding company that operates through its wholly owned subsidiary and specializes in last-mile delivery services within California. Its core business focuses on retrieving packages from distribution hubs and ensuring their prompt and secure delivery to recipients' doorsteps. Committed to innovation and efficiency, its mission is to optimize last-mile logistics by providing efficient, reliable, and innovative delivery solutions. The company mainly competes in the route delivery industry, which has several material barriers of entry, including: Substantial time and capital investment, Technological proficiency, Regulatory barriers, Balancing service quality and cost efficiency, and Effective Management.

About BRTX BioRestorative Therapies Inc. (NV)

BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.

Share on Social Networks: